What are the clinical benefits of recombinant gonadotrophins?: the development of recombinant FSH (Puregon((R))): a scientific business.
作者信息
Out H J, Bennink H J, de Laat W N
机构信息
Organon Laboratories Ltd, Science Park, Milton Road, Cambridge CB4 0FL, UK, and NV Organon, Oss, The Netherlands.
出版信息
Hum Reprod. 1999 Sep;14(9):2189-90. doi: 10.1093/humrep/14.9.2189.
PMID:10469679
Abstract
摘要
相似文献
1
What are the clinical benefits of recombinant gonadotrophins?: the development of recombinant FSH (Puregon((R))): a scientific business.重组促性腺激素的临床益处有哪些？重组促卵泡素（普丽康）的研发：一项科学事业。
Hum Reprod. 1999 Sep;14(9):2189-90. doi: 10.1093/humrep/14.9.2189.
2
What are the clinical benefits of recombinant gonadotrophins? Is Puregon a 'good' or'super' drug?重组促性腺激素的临床益处有哪些？果纳芬是一种“好”药还是“超级”药物？
Hum Reprod. 1999 Jun;14(6):1409-11. doi: 10.1093/humrep/14.6.1409.
3
Comparison of two recombinant follicle-stimulating hormone preparations in in-vitro fertilization: a randomized clinical study.两种重组促卵泡激素制剂在体外受精中的比较：一项随机临床研究。
Hum Reprod. 1999 Nov;14(11):2709-15. doi: 10.1093/humrep/14.11.2709.
4
A prospective, randomized, assessor-blind, multicentre study comparing recombinant and urinary follicle stimulating hormone (Puregon versus Metrodin) in in-vitro fertilization.一项前瞻性、随机、评估者盲法、多中心研究，比较重组卵泡刺激素与尿源性卵泡刺激素（果纳芬与美诺孕）在体外受精中的应用。
Hum Reprod. 1995 Oct;10(10):2534-40. doi: 10.1093/oxfordjournals.humrep.a135740.
5
A prospective randomized clinical trial comparing recombinant follicle stimulating hormone (Puregon) and human menopausal gonadotrophins (Humegon) in non-down-regulated in-vitro fertilization patients.
Hum Reprod. 1998 Nov;13(11):2995-9. doi: 10.1093/humrep/13.11.2995.
6
Delivery rates following IVF treatment, using two recombinant FSH preparations for ovarian stimulation.使用两种重组促卵泡激素制剂进行卵巢刺激的体外受精治疗后的分娩率。
Hum Reprod. 2002 Feb;17(2):304-9. doi: 10.1093/humrep/17.2.304.
7
The use of a 100 IU starting dose of recombinant follicle stimulating hormone (Puregon) in in-vitro fertilization.
Hum Reprod. 1998 Mar;13(3):565-6. doi: 10.1093/humrep/13.3.565.
8
A prospective, randomized clinical trial comparing 150 IU recombinant follicle stimulating hormone (Puregon((R))) and 225 IU highly purified urinary follicle stimulating hormone (Metrodin-HP((R))) in a fixed-dose regimen in women undergoing ovarian stimulation.
Hum Reprod. 1999 Oct;14(10):2442-7. doi: 10.1093/humrep/14.10.2442.
9
Ovulation induction with low dose alternate day recombinant follicle stimulating hormone (Puregon).
Hum Reprod. 1999 Dec;14(12):2969-73. doi: 10.1093/humrep/14.12.2969.
10
New stimulation regimens with recombinant FSH (Puregon) in in-vitro fertilization.重组促卵泡素（果纳芬）在体外受精中的新刺激方案。
Eur J Obstet Gynecol Reprod Biol. 1999 Jul;85(1):21-2. doi: 10.1016/s0301-2115(98)00277-2.
Zotero 插件